Dr Venessa Pattullo

Clinical Senior Lecturer
Medicine, Northern Clinical School

Telephone 02 9463 2450
Fax 02 9463 2041

Map

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Pattullo, V., George, J. (2012). The Problem of Insulin Resistance and its Effect on Therapy. In Geoffrey W. McCaughan, John G. McHutchison, Jean-Michel Pawlotsky (Eds.), Advanced Therapy for Hepatitis C, (pp. 169-176). Chichester, United Kingdom: Wiley-Blackwell Publishing.
  • Pattullo, V., George, J. (2010). Managing the Patient with Chronic Viral Hepatitis Receiving Chemotherapy. In Monica Robotin, Ian Olver and Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 813-832). London: Imperial College Press.
  • Pattullo, V., Heathcote, E. (2010). Morbid obesity and HCV: management strategies. In Graham R. Foster & K. Rajender Reddy (Eds.), Clinical Dilemmas in Viral Liver Disease, (pp. 61-64). Oxford: Wiley-Blackwell Publishing.

Journals

  • Pattullo, V., Duarte-Rojo, A., Soliman, W., Vargas-Vorackova, F., Sockalingam, S., Fantus, I., Allard, J., Heathcote, J. (2013). A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C. Liver International, 33(3), 410-419. [More Information]
  • Chen, F., Coyle, L., Jones, B., Pattullo, V. (2013). Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease. Liver International, 33(8), 1203-1210. [More Information]
  • Pattullo, V., Thein, H., Heathcote, E., Guindi, M. (2012). Combining semiquantitative measures of fibrosis and qualitative features of parenchymal remodelling to identify fibrosis regression in hepatitis C: a multiple biopsy study. Histopathology, 61(3), 473-487. [More Information]
  • Mcgilvray, I., Feld, J., Chen, L., Pattullo, V., Guindi, M., Fischer, S., Borozan, I., Xie, G., Selzner, N., Heathcote, E., et al (2012). Hepatic Cell-Type Specific Gene Expression Better Predicts HCV Treatment Outcome Than IL28B Genotype. Gastroenterology, 142(5), 1122-1131.e1. [More Information]
  • Pattullo, V., McAndrews, M., Damyanovich, A., Heathcote, E. (2011). Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes. Liver International, 31(7), 1028-1038. [More Information]
  • Pattullo, V., Douglas, M., George, J. (2011). Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis? Expert Review of Gastroenterology and Hepatology, 5(2), 265-277. [More Information]
  • Pattullo, V., Alkazaz, N., Sockalingam, S., Heathcote, E. (2011). Poor Perception of Body Weight Category amongst the Overweight and Obese with Chronic Hepatitis C: A Target for Intervention. Journal of Obesity, 2011, 1-8. [More Information]
  • Pattullo, V., Heathcote, E. (2010). Hepatitis C and diabetes: one treatment for two diseases? Liver International, 30(3), 356-364. [More Information]
  • Pattullo, V., Ravindran, N., Mazzulli, T., Wong, D., Heathcote, E. (2010). Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C. Journal of Viral Hepatitis, 17(12), 834-838. [More Information]
  • Pattullo, V., Heathcote, E., Wong, D. (2010). Superior Response to Pegylated Interferon and Ribavirin in Asians with Chronic Hepatitis C. Hepatology International, 4(4), 723-731. [More Information]
  • Pattullo, V., Guindi, M., Herzenberg, A., Scholey, J., Wong, F. (2010). Unexpected renal and liver failure. The American Journal of Medicine, 123(9), 799-801. [More Information]

2013

  • Pattullo, V., Duarte-Rojo, A., Soliman, W., Vargas-Vorackova, F., Sockalingam, S., Fantus, I., Allard, J., Heathcote, J. (2013). A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C. Liver International, 33(3), 410-419. [More Information]
  • Chen, F., Coyle, L., Jones, B., Pattullo, V. (2013). Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease. Liver International, 33(8), 1203-1210. [More Information]

2012

  • Pattullo, V., Thein, H., Heathcote, E., Guindi, M. (2012). Combining semiquantitative measures of fibrosis and qualitative features of parenchymal remodelling to identify fibrosis regression in hepatitis C: a multiple biopsy study. Histopathology, 61(3), 473-487. [More Information]
  • Mcgilvray, I., Feld, J., Chen, L., Pattullo, V., Guindi, M., Fischer, S., Borozan, I., Xie, G., Selzner, N., Heathcote, E., et al (2012). Hepatic Cell-Type Specific Gene Expression Better Predicts HCV Treatment Outcome Than IL28B Genotype. Gastroenterology, 142(5), 1122-1131.e1. [More Information]
  • Pattullo, V., George, J. (2012). The Problem of Insulin Resistance and its Effect on Therapy. In Geoffrey W. McCaughan, John G. McHutchison, Jean-Michel Pawlotsky (Eds.), Advanced Therapy for Hepatitis C, (pp. 169-176). Chichester, United Kingdom: Wiley-Blackwell Publishing.

2011

  • Pattullo, V., McAndrews, M., Damyanovich, A., Heathcote, E. (2011). Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes. Liver International, 31(7), 1028-1038. [More Information]
  • Pattullo, V., Douglas, M., George, J. (2011). Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis? Expert Review of Gastroenterology and Hepatology, 5(2), 265-277. [More Information]
  • Pattullo, V., Alkazaz, N., Sockalingam, S., Heathcote, E. (2011). Poor Perception of Body Weight Category amongst the Overweight and Obese with Chronic Hepatitis C: A Target for Intervention. Journal of Obesity, 2011, 1-8. [More Information]

2010

  • Pattullo, V., Heathcote, E. (2010). Hepatitis C and diabetes: one treatment for two diseases? Liver International, 30(3), 356-364. [More Information]
  • Pattullo, V., George, J. (2010). Managing the Patient with Chronic Viral Hepatitis Receiving Chemotherapy. In Monica Robotin, Ian Olver and Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 813-832). London: Imperial College Press.
  • Pattullo, V., Heathcote, E. (2010). Morbid obesity and HCV: management strategies. In Graham R. Foster & K. Rajender Reddy (Eds.), Clinical Dilemmas in Viral Liver Disease, (pp. 61-64). Oxford: Wiley-Blackwell Publishing.
  • Pattullo, V., Ravindran, N., Mazzulli, T., Wong, D., Heathcote, E. (2010). Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C. Journal of Viral Hepatitis, 17(12), 834-838. [More Information]
  • Pattullo, V., Heathcote, E., Wong, D. (2010). Superior Response to Pegylated Interferon and Ribavirin in Asians with Chronic Hepatitis C. Hepatology International, 4(4), 723-731. [More Information]
  • Pattullo, V., Guindi, M., Herzenberg, A., Scholey, J., Wong, F. (2010). Unexpected renal and liver failure. The American Journal of Medicine, 123(9), 799-801. [More Information]

To update your profile click here. For support on your academic profile contact .